Different perspectives on the key US market as half-year result looms.
Tue, 18 Oct 2016
First NZ Capital’s Tristan Joll remains bullish on Xero’s prospects with a new research note issued today, which reiterates an outperform rating. His 12-month target is $20.90 (a shade down on the previous $21.00; in late afternoon trading, Xero shares were up 2.3% to $17.89).
He says “the market
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).